Teresa Ho
Memorial Sloan Kettering Cancer Center(US)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Cancer Genomics and Diagnostics, Renal and related cancers, Lung Cancer Treatments and Mutations, Bladder and Urothelial Cancer Treatments
Most-Cited Works
- → Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer(2015)7,864 cited
- → Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma(2014)4,353 cited
- → Preoperative checkpoint inhibition (CPI) and cryoablation (Cryo) in women with early-stage breast cancer (ESBC).(2019)9 cited
- → Correlation of peripheral blood monocytic myeloid-derived suppressor cells (M-MDSC) and T-cell receptor (TCR) dynamics with clinical outcomes in patients (pts) with metastatic urothelial carcinoma (mUC) treated with nivolumab (NIVO).(2024)1 cited
- → Combining a WT1 cancer vaccine (galinpepimut-S) with checkpoint inhibition (nivolumab) in patients with WT1-expressing diffuse pleural mesothelioma (DPM): A phase I study.(2024)1 cited
- → Combining a WT1 Vaccine (Galinpepimut-S) With Checkpoint Inhibition (Nivolumab) in Patients With WT1–Expressing Diffuse Pleural Mesothelioma: A Phase 1 Study(2024)